Report DMCA Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ili
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.